United States· US:81279-104_2ef9fa55-cdc3-dc0a-e063-6394a90a0e5f
Ergomar
A ergotamine product containing ergotamine tartrate, registered in United States by Pangea Pharmaceuticals LLC. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Ergotamine is registered in 4 of 19 countries.
Countries holding a registration under ATC N02CA02 (ergotamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Ergotamine · ATC N02CA02
4 / 19 countries
- Finlandprice
- Germany
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ERGOTAMINE TARTRATE
- Manufacturer
- Pangea Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- N02CA02
- ATC class
- Ergotamine
- Defined daily dose
- 4 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1181279104031 BLISTER PACK in 1 CARTON (81279-104-03) / 3 TABLET in 1 BLISTER PACK
- ndc1181279104202 BLISTER PACK in 1 CARTON (81279-104-20) / 10 TABLET in 1 BLISTER PACK
- ndc1181279-104-03
- ndc1181279-104-20
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
144 interactions on record for ergotamine.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ergotamine · interactions on record
144 records
- 51 severe
- 92 moderate
- 1 minor
Most severe, free to view
- EpinephrineA01AD01severe
- IsomethepteneA03AX10severe
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ergotamine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMigril tabletsWockhardt UK Ltd
- BelgiumCafergot 1 mg - 100 mgAmdipharm
- GermanyErgo-Kranit MigräneFairmed Healthcare Gmbh
- PolandErgotaminum FilofarmFarmaceutyczna Spółdzielnia Pracy FILOFARM
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Ergo-Kranit Migräne
- Hungary · Ergam
- Poland · Ergotaminum Filofarm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/258a8b94-1f7e-4353-b8a4-e79fce0850ad GET /v1/drugs/258a8b94-1f7e-4353-b8a4-e79fce0850ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2",
"substance": "ERGOTAMINE TARTRATE",
"productndc": "81279-104",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA087693",
"marketing_category": "ANDA"
}See everything about ergotamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.